Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2022

Open Access 01-12-2022 | Breast Cancer | Study protocol

An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial

Authors: Victoria S. Blinder, Sujata Patil, Jackie Finik, Della Makower, Monica Muppidi, Wendy G. Lichtenthal, Patricia A. Parker, Maria Claros, Jennifer Suarez, Bharat Narang, Francesca Gany

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Job loss after a cancer diagnosis can lead to long-term financial toxicity and its attendant adverse clinical consequences, including decreased treatment adherence. Among women undergoing (neo)adjuvant chemotherapy for breast cancer, access to work accommodations (e.g., sick leave) is associated with higher job retention after treatment completion. However, low-income and/or minority women are less likely to have access to work accommodations and, therefore, are at higher risk of job loss. Given the time and transportation barriers that low-income working patients commonly face, it is crucial to develop an intervention that is convenient and easy to use.

Methods

We designed an intervention to promote job retention during and after (neo)adjuvant chemotherapy for breast cancer by improving access to relevant accommodations. Talking to Employers And Medical staff about Work (TEAMWork) is an English/Spanish mobile application (app) that provides (1) suggestions for work accommodations tailored to specific job demands, (2) coaching/strategies for negotiating with an employer, (3) advice for symptom self-management, and (4) tools to improve communication with the medical oncology team. This study is a randomized controlled trial to evaluate the app as a job-retention tool compared to a control condition that provides the app content in an informational paper booklet. The primary outcome of the study is work status after treatment completion. Secondary outcomes include work status 1 and 2 years later, participant self-efficacy to ask an employer for accommodations, receipt of workplace accommodations during and following adjuvant therapy, patient self-efficacy to communicate with the oncology provider, self-reported symptom burden during and following adjuvant therapy, and cancer treatment adherence.

Discussion

This study will assess the use of mobile technology to improve vulnerable breast cancer patients’ ability to communicate with their employers and oncology providers, work during treatment and retain their jobs in the long term, thereby diminishing the potential consequences of job loss, including decreased treatment adherence, debt, and bankruptcy.

Trial registration

ClincalTrials.gov NCT03572374. Registered on 08 June 2018.
Appendix
Available only for authorised users
Literature
1.
Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Graff J, et al. Racial/ethnic differences in job loss for women with breast cancer. J Cancer Surviv. 2011;5(1):102–11.PubMedCrossRef
2.
Banegas MP, Guy GP Jr, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Project Hope). 2016;35(1):54–61.CrossRef
3.
Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Project Hope). 2013;32(6):1143–52.CrossRef
4.
Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980–6.PubMedPubMedCentralCrossRef
5.
Blinder V, Patil S, Eberle C, Griggs J, Maly RC. Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study. Breast Cancer Res Treat. 2013;140(2):407–16.PubMedCrossRef
6.
Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ. The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat. 2010;119(1):213–20.PubMedCrossRef
7.
Blinder V, Eberle C, Patil S, Gany FM, Bradley CJ. Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Aff (Millwood). 2017;36(2):274–81.CrossRef
8.
Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006;24(3):345–53.PubMedCrossRef
9.
Satariano WA, DeLorenze GN. The likelihood of returning to work after breast cancer. Public Health Rep. 1996;111(3):236–41.PubMedPubMedCentral
10.
Jagsi R, Hawley ST, Abrahamse P, Li Y, Janz NK, Griggs JJ, et al. Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer. 2014;120(12):1854–62.PubMedCrossRef
11.
Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E, et al. Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study. Cancer. 2012;118(6):1664–74.PubMedCrossRef
12.
13.
14.
15.
16.
Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, et al. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: results from a substudy of the VIRGO observational cohort study. Breast. 2014;23(6):763–9.PubMedCrossRef
17.
Blinder VS, Patil S, Gany F, Maly RC. Five-year trajectories of financial recovery in low-income breast cancer survivors. J Clin Oncol. 2013;31(15):9597.CrossRef
18.
Kaisaeng N, Harpe SE, Carroll NV. Out-of-pocket costs and oral cancer medication discontinuation in the elderly. J Manag Care Spec Pharm. 2014;20(7):669–75.PubMed
19.
Hershman DL, Tsui J, Meyer J, Glied S, Hillyer GC, Wright JD, et al. The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer. J Natl Cancer Inst. 2014;106(11):dju319.PubMedPubMedCentralCrossRef
20.
Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4):306–11.PubMedCrossRef
21.
Berry DL, Blonquist TM, Hong F, Halpenny B, Partridge AH. Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics. Patient Prefer Adherence. 2015;9:1587–92.PubMedPubMedCentralCrossRef
22.
Liu Y, Malin JL, Diamant AL, Thind A, Maly RC. Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication. Breast Cancer Res Treat. 2013;137(3):829–36.PubMedCrossRef
23.
Maly RC, Liu Y, Leake B, Thind A, Diamant AL. Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat. 2010;119(3):707–16.PubMedCrossRef
24.
Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, et al. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv. 2013;7(2):191–202.PubMedPubMedCentralCrossRef
25.
26.
Glanz K, Rimer BK, Lewis FM. Health behavior and health education: theory, research and practice. San Fransisco: Wiley; 2002.
27.
Moore PM, Rivera Mercado S, Grez Artigues M, Lawrie TA. Communication skills training for healthcare professionals working with people who have cancer. Cochrane Database Syst Rev. 2013;3:CD003751.
28.
Cegala DJ, Post DM, McClure L. The effects of patient communication skills training on the discourse of older patients during a primary care interview. J Am Geriatr Soc. 2001;49(11):1505–11.PubMedCrossRef
29.
Brandes K, Linn AJ, Butow PN, van Weert JC. The characteristics and effectiveness of Question Prompt List interventions in oncology: a systematic review of the literature. Psychooncology. 2015;24(3):245–52.PubMedCrossRef
30.
Friedman AJ, Cosby R, Boyko S, Hatton-Bauer J, Turnbull G. Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations. J Cancer Educ. 2011;26(1):12–21.PubMedCrossRef
31.
Goss C, Ghilardi A, Deledda G, Buizza C, Bottacini A, Del Piccolo L, et al. INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocol. BMJ Open. 2013;3(5):e002266.PubMedPubMedCentralCrossRef
32.
Henselmans I, de Haes HC, Smets EM. Enhancing patient participation in oncology consultations: a best evidence synthesis of patient-targeted interventions. Psychooncology. 2013;22(5):961–77.PubMedCrossRef
33.
Shirai Y, Fujimori M, Ogawa A, Yamada Y, Nishiwaki Y, Ohtsu A, et al. Patients’ perception of the usefulness of a question prompt sheet for advanced cancer patients when deciding the initial treatment: a randomized, controlled trial. Psychooncology. 2012;21(7):706–13.PubMedCrossRef
34.
Maly RC, Griggs J, Liang L-J, Dauphine C, Tripathy D, Ganz PA. A randomized controlled trial of survivorship care plans among low-income breast cancer survivors. San Francisco: ASCO Cancer Survivorship Symposium: Advancing Care and Research, A Primary Care and Oncology Collaboration; 2016.
35.
Brown RF, Owens M, Bradley C. Employee to employer communication skills: balancing cancer treatment and employment. Psychooncology. 2013;22:426–33.PubMed
36.
Hasin DS, Aharonovich E, Greenstein E. HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients. Addict Sci Clin Pract. 2014;9:5.PubMedPubMedCentralCrossRef
37.
Mitchell SJ, Godoy L, Shabazz K, Horn IB. Internet and mobile technology use among urban African American parents: survey study of a clinical population. J Med Internet Res. 2014;16(1):e9.PubMedPubMedCentralCrossRef
38.
39.
Steiner JF, Cavender TA, Main DS, Bradley CJ. Assessing the impact of cancer on work outcomes: what are the research needs? Cancer. 2004;101(8):1703–11.PubMedCrossRef
40.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. J Am Med Assoc. 1995;273(1):59–65.CrossRef
41.
Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res. 2007;16(3):413–28.PubMedCrossRef
42.
Blinder VS, Murphy MM, Vahdat LT, Gold HT, de Melo-Martin I, Hayes MK, et al. Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women. J Community Health. 2012;37(4):763–72.PubMedCrossRef
43.
Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med. 1981;304(1):10–5.PubMedCrossRef
44.
Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med. 1995;332(14):901–6.PubMedCrossRef
45.
Lyman GH, Dale DC, Crawford J. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol. 2003;21(24):4524–31.PubMedCrossRef
46.
47.
Nielsen J, Landauer TK. A mathematical model of the finding of usability problems. In: Proceedings of the SIGCHI conference on human factors in computing systems – CHI’93; April 24-29, 1993. Amsterdam: Associate for Computing Machinery; 1993. p. 206–13.
48.
Department of Health and Human Services. Research-based web design and usability guidelines. Department of Health and Human Services. Available from: http://​www.​usability.​gov; Accessed 4 July 2022.
49.
Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726–32.PubMedCrossRef
50.
51.
Liu Y, Diamant AL, Thind A, Maly RC. Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer. Breast Cancer Res Treat. 2010;119(3):745–51.PubMedCrossRef
52.
Marin G, Sabogal F, Marin B, Otero-Sabogal R, Perez-Stable E. Development of a short acculturation scale for Hispanics. Hisp J Behav Sci. 1987;9(2):183–205.CrossRef
53.
Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73–84.PubMedCrossRef
54.
Chen JY, Diamant AL, Thind A, Maly RC. Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer. 2008;112(5):1153–61.PubMedCrossRef
55.
Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB. Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998;46(7):889–94.PubMedCrossRef
56.
Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof. 2005;28(2):212–32.PubMedCrossRef
57.
Arnold B, Mitchell SA, Lent L, Mendoza TR, Rogak LJ, Barragan NM, et al. Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Support Care Cancer. 2016;24(7):2843–51.PubMedCrossRef
58.
Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, et al. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015;1(8):1051–9.PubMedPubMedCentralCrossRef
59.
Mendoza TR, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, Li Y, et al. Impact of recall period on the accuracy of selected items from the US National Cancer Institute’s Patient-Reported Outcomes version fo the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Berlin: International Society for Quality of Life Research; 2014.
60.
Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs: Prentice-Hall; 1980.
61.
Bandura A, National Inst of Mental Health. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs: Prentice-Hall, Inc.; 1986.
62.
Elderkin-Thompson V, Waitzkin H. Using video tapes in qualitative research. In: Crabtree BF, Miller WL, editors. Doing qualitative research. Thousand Oaks: Sage Publications; 1999.
63.
Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ. 2012;345:e5840.PubMedPubMedCentralCrossRef
64.
Ibrahim JG, Molenberghs G. Missing data methods in longitudinal studies: a review. Test. 2009;18(1):1–43.PubMedCrossRef
Metadata
Title
An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial
Authors
Victoria S. Blinder
Sujata Patil
Jackie Finik
Della Makower
Monica Muppidi
Wendy G. Lichtenthal
Patricia A. Parker
Maria Claros
Jennifer Suarez
Bharat Narang
Francesca Gany
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06580-7

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue

Study protocol

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application

Study protocol

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

Study protocol

The Knee-Fix study: study protocol for a randomised controlled trial evaluating cemented and cementless components in total knee arthroplasty

Study protocol

Effects of alpha-lipoic acid on sperm quality in patients with varicocele-related male infertility: study protocol for a randomized controlled clinical trial

Study protocol

Efficacy and cerebral mechanism of acupuncture and moxibustion for treating primary dysmenorrhea: study protocol for a randomized controlled clinical trial

Study protocol

Implementation of an in situ simulation-based training adapted from Morbidity and Mortality conference cases: effect on the occurrence of adverse events—study protocol of a cluster randomised controlled trial